Dr. Arulkumar Nagappan is a researcher at the Laboratory of Mucosal Exposome and Biomodulation, Department of Integrative Biomedical Sciences, Biomedical Research Institute, Pusan ​​National University, Yangsan, South Korea. His research focuses on bio-active compounds and their roles in cancer metabolism, apoptosis, oxidative stress, and chemoresistance. He is dedicated to exploring molecular mechanisms underlying cancer progression and resistance, aiming to identify potential therapeutic targets and strategies for improved treatment outcomes.